A detailed history of Financial Guidance Group, Inc. transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Financial Guidance Group, Inc. holds 21,945 shares of DRTS stock, worth $67,590. This represents 0.03% of its overall portfolio holdings.

Number of Shares
21,945
Previous 21,945 -0.0%
Holding current value
$67,590
Previous $55,000 5.45%
% of portfolio
0.03%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$2.05 - $2.9 $20,500 - $29,000
10,000 Added 83.72%
21,945 $55,000
Q4 2023

Jan 26, 2024

BUY
$2.75 - $3.89 $4,633 - $6,554
1,685 Added 16.42%
11,945 $35,000
Q3 2022

Oct 25, 2022

BUY
$0.65 - $11.0 $6,669 - $112,860
10,260 New
10,260 $60,000

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $213M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Financial Guidance Group, Inc. Portfolio

Follow Financial Guidance Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Guidance Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Guidance Group, Inc. with notifications on news.